ECSP972274A - MYCOSIS VACCINES - Google Patents

MYCOSIS VACCINES

Info

Publication number
ECSP972274A
ECSP972274A ECSP972274A ECSP972274A EC SP972274 A ECSP972274 A EC SP972274A EC SP972274 A ECSP972274 A EC SP972274A EC SP972274 A ECSP972274 A EC SP972274A
Authority
EC
Ecuador
Prior art keywords
vaccines
mycosis
prophylaxis
inactivated
treatment
Prior art date
Application number
Other languages
Spanish (es)
Inventor
Pollakov Igor Dimitrievich
Ludmilla G Ivanova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to ECSP972274 priority Critical patent/ECSP972274A/en
Publication of ECSP972274A publication Critical patent/ECSP972274A/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

El presente invento se refiere a vacunas que comprenden blastoesporas de levadura inactivadas y homogeneizadas y microconidios de dermatofitos inactivados y homogeneizados o el material antigénico de dichas esporas, a métodos para su producción y a su uso para la profilaxis y/o el tratamiento de micosis en mamíferos, preferiblemente seres humanos. Las vacunas de acuerdo con el presente invento son especialmente útiles para la profilaxis y/o el tratamiento de micosis cutáneas, preferiblemente dermatomicosis y/o candidosis y/u onicomicosis.The present invention relates to vaccines comprising inactivated and homogenized yeast blastopores and microconidia of inactivated and homogenized dermatophytes or the antigenic material of said spores, to methods for their production and their use for the prophylaxis and / or treatment of mycoses in mammals. , preferably human beings. Vaccines according to the present invention are especially useful for the prophylaxis and / or treatment of cutaneous mycoses, preferably dermatomycosis and / or candidiasis and / or onychomycosis.

ECSP972274 1997-10-01 1997-10-01 MYCOSIS VACCINES ECSP972274A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ECSP972274 ECSP972274A (en) 1997-10-01 1997-10-01 MYCOSIS VACCINES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ECSP972274 ECSP972274A (en) 1997-10-01 1997-10-01 MYCOSIS VACCINES

Publications (1)

Publication Number Publication Date
ECSP972274A true ECSP972274A (en) 1998-11-30

Family

ID=42043105

Family Applications (1)

Application Number Title Priority Date Filing Date
ECSP972274 ECSP972274A (en) 1997-10-01 1997-10-01 MYCOSIS VACCINES

Country Status (1)

Country Link
EC (1) ECSP972274A (en)

Similar Documents

Publication Publication Date Title
AR008491A1 (en) VACCINE AGAINST MYCOSIS, PROCEDURE FOR ITS PREPARATION AND USE FOR PROPHYLAXIS AND / OR TREATMENT OF MYCOSIS
CY1106429T1 (en) PILLOW SUITABLE FOR THE FEMALE BODY
ES2145428T3 (en) USE OF PRODUCTS OF ALCOXILACION OF FATS EPOXIDADAS AS DESPUMANTS.
LTIP888A (en) Polyethylene glycol -interferon conjugates
AR015257A1 (en) AN ACIDIFIED COMPOSITION AND THE USE OF THE SUCH COMPOSITION FOR THE MANUFACTURE OF A MEDICINAL PRODUCT FOR THE TOPICAL TREATMENT OF UNIQUE AND SKIN CONDITIONS
ES2164251T3 (en) VACCINE THAT INCLUDES AN ANTIGEN CONJUGATE POLISACARIDO-PROTEIN TRANSPORTER AND PROTEIN FREE CARRIER.
ES2316403T3 (en) COSMETIC COMPOSITION CONTAINING AN ANTAGONIST OF NEUROPEPTIDE RECEIVERS AND.
PT1411908E (en) TREATMENT OF INFECTIONS OF THE
ES2056954T3 (en) CYCLIC PEPTOLIDS.
ES2170259T3 (en) EMPLOYMENT OF LIPIDS AS AUXILIARY AGENTS IN OBTAINING SOLID PHARMACEUTICAL FORMS ACCORDING TO THE FUSION EXTRUSION PROCEDURE.
CL2022001185A1 (en) Therapeutic derivatives of interleukin-22
DE69501978D1 (en) Rolling device for elongated objects, in particular for the manufacture of tobacco products
NO964238L (en) Halofantrine-free base for the treatment of malaria and mixtures
MX9205358A (en) COMPOUNDS TO TREAT DISEASES RELATED TO LEUKOTRENE.
ECSP972274A (en) MYCOSIS VACCINES
ES2194104T3 (en) USE OF SELEGYLINE FOR THE TREATMENT OF LOSS OF HEARING IN MAMMALS.
MX9801180A (en) ANTIGENIC PREPARATIONS.
ES2177987T3 (en) MOLDED ITEMS OF HYDRATIONED CELLULOSE WITH ENZYMATICALLY MODIFIED SURFACE.
ES2145114T3 (en) COMBINATION OF ATOVACUONA WITH PROGUANIL FOR THE TREATMENT OF PROTOZOARY INFECTIONS.
UY27312A1 (en) NEW HETEROCICLOS 3
AR029451A1 (en) A COMPOSITION FOR USE IN THE BREAST CANCER THERAPY IN HUMAN BEINGS AND A PRODUCT FOR USE IN SUCH THERAPY
ES2189206T3 (en) BETA-ALCOXIACRYLATES AGAINST MALARIA.
UY24853A1 (en) PROCEDURE FOR PREPARING MYCOSIS VACCINES
ES2117475T3 (en) USE OF MONOCARBOXILIC ACIDS FOR THE TREATMENT OF KERATINIC MATERIALS.
EP4514344A4 (en) Lipids, formulations and uses thereof